[Patient Centeredness and Decision-making in Localised Prostate Cancer: Possible Fields of Health Services Research in Urology]

Overview

Journal Urologe A

Specialty Urology

Date 2011 Jun 10

PMID 21656094

Citations 9

Authors

J Huber

A Ihrig

C G Huber

B Hadaschik

S Pahernik

M Hohenfellner

Affiliations

Soon will be listed here.

Abstract

Background: Quality of care is essential for health services research. Therefore, our patients' preferences are of major importance and this can be illustrated by decision-making in localised prostate cancer.

Material And Methods: A total of 349 patients reported on their preferred mode of decision-making, on their habits of information procurement, and on their feeling of being well informed. Moreover, we tried to objectify their actual knowledge. Their mean age was 63.0 years and mean PSA level 9.4 ng/ml. As 40% had a higher level of education we investigated possible influences of this feature by applying the chi-square test.

Results: Half of the patients preferred to share the treatment decision and 39% wanted to choose for themselves considering their physician's recommendation. The most important sources of information were treating physicians (88%) and the Internet (77%). All patients felt well informed and 94% knew their latest PSA count. Patients with a higher level of education had better knowledge of their clinical data and used the Internet more (84 vs 71%; p=0.007).

Conclusions: Our patients actively take part in medical decision-making and thereby contribute significantly to everyday health care. Based on this aspect, the whole scope of urology is developed as a promising field of health services research.

Citing Articles

Prevalence and determinants of decision regret in long-term prostate cancer survivors following radical prostatectomy.

Lunger L, Meissner V, Kopp B, Dinkel A, Schiele S, Ankerst D BMC Urol. 2023; 23(1):139.

PMID: 37612591 PMC: 10464370. DOI: 10.1186/s12894-023-01311-9.

[Patient events in German urology: trend towards hybrid formats?].

Karschuck P, Muller L, Groeben C, Aksoy C, Flegar L, Zacharis A Urologie. 2023; 63(1):75-82.

PMID: 37566223 PMC: 10791946. DOI: 10.1007/s00120-023-02162-w.

The Treatment Decision-making Preferences of Patients with Prostate Cancer Should Be Recorded in Research and Clinical Routine: a Pooled Analysis of Four Survey Studies with 7169 Patients.

Ihrig A, Maatouk I, Friederich H, Baunacke M, Groeben C, Koch R J Cancer Educ. 2020; 37(3):675-682.

PMID: 32940881 PMC: 9205804. DOI: 10.1007/s13187-020-01867-2.

["Dr. Google"-information-seeking behavior and disease-specific anxiety among men with localized prostate cancer].

Hilger C, Otto I, Hill C, Huber T, Kendel F Urologe A. 2018; 58(9):1050-1056.

PMID: 30178295 DOI: 10.1007/s00120-018-0769-1.

[Evaluation of the decision aid "Entscheidungshilfe Prostatakrebs" from the patients' view : Results from the first three months].

Groeben C, Ihrig A, Holscher T, Krones T, Kessler E, Kliesch S Urologe A. 2016; 55(12):1586-1594.

PMID: 27826660 DOI: 10.1007/s00120-016-0265-4.

References

Huber J, Peters T, Kessler A, Ihrig A, Huber C, Hadaschik B . [Online support groups for localized prostate cancer: qualitative analysis of decision making]. Urologe A. 2010; 49(11):1377-84. DOI: 10.1007/s00120-010-2363-z. View

Moore R, Gavaghan D, Edwards J, Wiffen P, McQuay H . Pooling data for number needed to treat: no problems for apples. BMC Med Res Methodol. 2002; 2:2. PMC: 65633. DOI: 10.1186/1471-2288-2-2. View

Schrappe M, Pfaff H . [Health services research: concept and methods]. Dtsch Med Wochenschr. 2011; 136(8):381-6. DOI: 10.1055/s-0031-1272540. View

Pickles T, Ruether J, Weir L, Carlson L, Jakulj F . Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance. BJU Int. 2007; 100(3):544-51. DOI: 10.1111/j.1464-410X.2007.06981.x. View

Degner L, Sloan J . Decision making during serious illness: what role do patients really want to play?. J Clin Epidemiol. 1992; 45(9):941-50. DOI: 10.1016/0895-4356(92)90110-9. View

Tosoian J, Trock B, Landis P, Feng Z, Epstein J, Partin A . Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J Clin Oncol. 2011; 29(16):2185-90. DOI: 10.1200/JCO.2010.32.8112. View

Schnell D, Schon H, Weissbach L . [Therapy of local prostate carcinoma. Questions answered by outcome research]. Urologe A. 2009; 48(9):1050-5. DOI: 10.1007/s00120-009-2082-5. View

Volk R, Hawley S, Kneuper S, Holden E, Stroud L, Cooper C . Trials of decision aids for prostate cancer screening: a systematic review. Am J Prev Med. 2007; 33(5):428-434. DOI: 10.1016/j.amepre.2007.07.030. View

Kummervold P, Chronaki C, Lausen B, Prokosch H, Rasmussen J, Santana S . eHealth trends in Europe 2005-2007: a population-based survey. J Med Internet Res. 2008; 10(4):e42. PMC: 2629359. DOI: 10.2196/jmir.1023. View

10.

Lavery H, Brajtbord J, Levinson A, Nabizada-Pace F, Pollard M, Samadi D . Unnecessary imaging for the staging of low-risk prostate cancer is common. Urology. 2010; 77(2):274-8. DOI: 10.1016/j.urology.2010.07.491. View

11.

Emanuel E, Emanuel L . Four models of the physician-patient relationship. JAMA. 1992; 267(16):2221-6. View

12.

OConnor A, Bennett C, Stacey D, Barry M, Col N, Eden K . Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009; (3):CD001431. DOI: 10.1002/14651858.CD001431.pub2. View

13.

Rollig C, Nothacker M, Wockel A, Weinbrenner S, Wirth M, Kopp I . Development of the interdisciplinary evidence-based s3 guideline for the diagnosis and treatment of prostate cancer: methodological challenges and solutions. Onkologie. 2010; 33(7):396-400. DOI: 10.1159/000315762. View

14.

van den Bergh R, Vasarainen H, van der Poel H, Vis-Maters J, Rietbergen J, Pickles T . Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study. BJU Int. 2009; 105(7):956-62. DOI: 10.1111/j.1464-410X.2009.08887.x. View